|
1
|
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
|
Nat Cell Biol
|
2008
|
19.86
|
|
2
|
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy.
|
Nat Med
|
2012
|
4.11
|
|
3
|
Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests.
|
J Neurosurg
|
2003
|
3.43
|
|
4
|
Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes.
|
Neurosurgery
|
2002
|
2.37
|
|
5
|
Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage.
|
Crit Care Med
|
2005
|
2.24
|
|
6
|
Frameless, real-time, surface imaging-guided radiosurgery: clinical outcomes for brain metastases.
|
Neurosurgery
|
2012
|
2.20
|
|
7
|
Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.
|
J Neurooncol
|
2013
|
1.88
|
|
8
|
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells.
|
Clin Cancer Res
|
2012
|
1.67
|
|
9
|
Adult-born and preexisting olfactory granule neurons undergo distinct experience-dependent modifications of their olfactory responses in vivo.
|
J Neurosci
|
2005
|
1.64
|
|
10
|
Microfluidic isolation and transcriptome analysis of serum microvesicles.
|
Lab Chip
|
2009
|
1.61
|
|
11
|
Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes.
|
Neurosurgery
|
2003
|
1.57
|
|
12
|
Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload.
|
J Neurosurg
|
2005
|
1.52
|
|
13
|
Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
|
Neurosurgery
|
2006
|
1.51
|
|
14
|
Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation.
|
J Neurosurg
|
2010
|
1.50
|
|
15
|
Results of a prospective protocol of computed tomographic angiography in place of catheter angiography as the only diagnostic and pretreatment planning study for cerebral aneurysms by a combined neurovascular team.
|
Neurosurgery
|
2004
|
1.50
|
|
16
|
Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.
|
Neuro Oncol
|
2005
|
1.50
|
|
17
|
Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
|
Neurosurgery
|
2009
|
1.47
|
|
18
|
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls.
|
BMC Cancer
|
2012
|
1.43
|
|
19
|
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles.
|
Mol Ther Nucleic Acids
|
2013
|
1.40
|
|
20
|
Genetically engineered T cells to target EGFRvIII expressing glioblastoma.
|
J Neurooncol
|
2009
|
1.40
|
|
21
|
Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010).
|
J Neurosurg
|
2014
|
1.36
|
|
22
|
Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors.
|
Neurosurgery
|
2006
|
1.30
|
|
23
|
Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
|
Stroke
|
2014
|
1.28
|
|
24
|
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.
|
PLoS One
|
2013
|
1.25
|
|
25
|
Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.
|
Proc Natl Acad Sci U S A
|
2002
|
1.20
|
|
26
|
Proposed use of prophylactic decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage patients presenting with associated large sylvian hematomas.
|
Neurosurgery
|
2002
|
1.13
|
|
27
|
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma.
|
Oncotarget
|
2014
|
1.11
|
|
28
|
Extracranial-intracranial bypass in the treatment of occlusive cerebrovascular disease and intracranial aneurysms in the United States between 1992 and 2001: a population-based study.
|
J Neurosurg
|
2005
|
1.08
|
|
29
|
Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004.
|
Neurosurgery
|
2010
|
1.07
|
|
30
|
Age-dependent differences in short-term outcome after surgical or endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000.
|
Neurosurgery
|
2004
|
1.07
|
|
31
|
Outcomes for surgical and endovascular management of intracranial aneurysms using a comprehensive grading system.
|
Neurosurgery
|
2006
|
1.01
|
|
32
|
Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases.
|
J Neurol Neurosurg Psychiatry
|
2013
|
1.00
|
|
33
|
Stratification of outcome for surgically treated unruptured intracranial aneurysms.
|
Neurosurgery
|
2003
|
0.99
|
|
34
|
Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage.
|
Neurosurgery
|
2004
|
0.97
|
|
35
|
In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume.
|
Neurosurgery
|
2003
|
0.96
|
|
36
|
ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
|
J Neurointerv Surg
|
2012
|
0.95
|
|
37
|
In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume.
|
AJNR Am J Neuroradiol
|
2003
|
0.94
|
|
38
|
Surgical excision of acoustic neuroma: patient outcome and provider caseload.
|
Laryngoscope
|
2003
|
0.92
|
|
39
|
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.
|
J Neurooncol
|
2015
|
0.90
|
|
40
|
Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients.
|
Expert Rev Mol Diagn
|
2014
|
0.90
|
|
41
|
Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm.
|
AJNR Am J Neuroradiol
|
2004
|
0.90
|
|
42
|
Important factors for a combined neurovascular team to consider in selecting a treatment modality for patients with previously clipped residual and recurrent intracranial aneurysms.
|
Neurosurgery
|
2003
|
0.88
|
|
43
|
Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas.
|
Neurosurgery
|
2007
|
0.87
|
|
44
|
Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter.
|
Neurocrit Care
|
2004
|
0.87
|
|
45
|
Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction.
|
Neurosurgery
|
2005
|
0.85
|
|
46
|
A review of lumbar spinal instrumentation: evidence and controversy.
|
J Neurol Neurosurg Psychiatry
|
2011
|
0.84
|
|
47
|
Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage.
|
Stroke
|
2009
|
0.84
|
|
48
|
Long-term follow-up of unruptured intracranial aneurysms repaired in California.
|
J Neurosurg
|
2014
|
0.83
|
|
49
|
Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis.
|
J Neurosurg
|
2013
|
0.83
|
|
50
|
Neuro-oncologic applications of exosomes, microvesicles, and other nano-sized extracellular particles.
|
Neurosurgery
|
2013
|
0.81
|
|
51
|
Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: A meta-analysis of controlled clinical trials.
|
Asian J Neurosurg
|
2011
|
0.81
|
|
52
|
Synthesizing medical evidence: systematic reviews and metaanalyses.
|
Neurosurg Focus
|
2005
|
0.81
|
|
53
|
Outcomes studies in cerebrovascular neurosurgery.
|
Neurosurg Focus
|
2007
|
0.81
|
|
54
|
Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.
|
J Neurosurg
|
2008
|
0.81
|
|
55
|
Genetic and cellular therapies for cerebral infarction.
|
Neurosurgery
|
2004
|
0.80
|
|
56
|
Ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis.
|
Surg Neurol Int
|
2012
|
0.79
|
|
57
|
High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study.
|
Neurocrit Care
|
2007
|
0.79
|
|
58
|
Genetic and cellular therapies for cerebral infarction.
|
Neurosurgery
|
2008
|
0.78
|
|
59
|
The Cancer Genome Atlas expression profiles of low-grade gliomas.
|
Neurosurg Focus
|
2014
|
0.78
|
|
60
|
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
|
J Neurooncol
|
2014
|
0.78
|
|
61
|
Thirty-Day Perioperative Outcomes in Spinal Fusion by Specialty Within the NSQIP Database.
|
Spine (Phila Pa 1976)
|
2015
|
0.77
|
|
62
|
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma.
|
J Neurooncol
|
2013
|
0.77
|
|
63
|
Hemicraniectomy for massive cerebral infarction.
|
Top Stroke Rehabil
|
2004
|
0.76
|
|
64
|
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy.
|
J Neurooncol
|
2012
|
0.76
|
|
65
|
ISAT subgroups: is aneurysm clipping better for some patients?
|
Neurosurgery
|
2008
|
0.76
|
|
66
|
Increased prevalence of obesity and obesity-related postoperative complications in male meningioma patients.
|
Clin Neurosurg
|
2007
|
0.76
|
|
67
|
Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy.
|
Neurosurgery
|
2002
|
0.75
|
|
68
|
Response.
|
J Neurosurg
|
2015
|
0.75
|
|
69
|
Response.
|
J Neurosurg
|
2015
|
0.75
|
|
70
|
339 Comparative Prognostic Value of the Cumulative Intracranial Tumor Volume and Score Index for Radiosurgery in Brain Metastasis.
|
Neurosurgery
|
2016
|
0.75
|
|
71
|
Surrogate measures of outcome in clinical trials: clues worth examining?
|
Neurosurgery
|
2008
|
0.75
|
|
72
|
Viral vectors: promising new therapeutics in the battle against glioblastoma.
|
Expert Rev Clin Pharmacol
|
2012
|
0.75
|
|
73
|
701 Combined Surgical and Endovascular Outcome in the Treatment of Paraclinoid Aneurysms.
|
Neurosurgery
|
2000
|
0.75
|
|
74
|
Low grade gliomas.
|
Neurosurg Focus
|
2013
|
0.75
|
|
75
|
Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model.
|
Neurosurgery
|
2016
|
0.75
|
|
76
|
A new era of outcomes research.
|
Neurosurgery
|
2009
|
0.75
|
|
77
|
Shunting for Alzheimer's disease: stymied by a different sort of placebo effect?
|
Neurosurgery
|
2008
|
0.75
|
|
78
|
Guidelines: Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas.
|
Neurosurgery
|
2016
|
0.75
|
|
79
|
Medical management of increased intracranial pressure after spontaneous intracerebral hemorrhage.
|
Neurosurg Clin N Am
|
2002
|
0.75
|
|
80
|
Big data and GME: expanding the scope of patient safety and QI training.
|
Bull Am Coll Surg
|
2015
|
0.75
|
|
81
|
Guidelines: Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Preoperative Imaging Assessment of Patients With Suspected Nonfunctioning Pituitary Adenomas.
|
Neurosurgery
|
2016
|
0.75
|